Drugs / RG-7795
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01211626 Comparator | Jun 2008 → Aug 2009 | chronic hepatitis C virus infection | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RG-7795 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650440 ↗ |
| Known as | ANA773 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01211626 ↗ |
| Route | Oral | “following oral administration to healthy volunteers” NCT01211626 ↗ |